291 related articles for article (PubMed ID: 7743827)
1. The beta-agonist controversy. Impact in COPD.
Ziment I
Chest; 1995 May; 107(5 Suppl):198S-205S. PubMed ID: 7743827
[No Abstract] [Full Text] [Related]
2. Beta-agonist therapy and asthma mortality in Japan.
Beasley R; Nishima S; Pearce N; Crane J
Lancet; 1998 May; 351(9113):1406-7. PubMed ID: 9593418
[No Abstract] [Full Text] [Related]
3. Is the routine use of inhaled beta-adrenergic agonists appropriate in asthma treatment? Yes.
Wanner A
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):597-9. PubMed ID: 7881643
[No Abstract] [Full Text] [Related]
4. Is the routine use of inhaled beta-adrenergic agonists appropriate in asthma treatment? No.
Sears MR
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):600-1. PubMed ID: 7881644
[No Abstract] [Full Text] [Related]
5. Salmeterol for the treatment of asthma.
Weinberger M
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):209-11. PubMed ID: 7552921
[No Abstract] [Full Text] [Related]
6. Present state of the controversy about regular inhaled beta-agonists in asthma.
Giuntini CG; Paggiaro PL
Eur Respir J; 1995 May; 8(5):673-8. PubMed ID: 7656934
[No Abstract] [Full Text] [Related]
7. Partial beta 2-agonists and their impartial assessment.
Dickey BF; Clark RC; Barber R
Chest; 1996 Nov; 110(5):1131-2. PubMed ID: 8915203
[No Abstract] [Full Text] [Related]
8. Bronchodilator therapy in chronic obstructive pulmonary disease.
Manning HL
Curr Opin Pulm Med; 2000 Mar; 6(2):99-103. PubMed ID: 10741767
[TBL] [Abstract][Full Text] [Related]
9. [Update on beta-adrenergic agonists and corticosteroid aerosols].
Spector S
Rev Alerg Mex; 1993; 40(6):i-iv. PubMed ID: 9296815
[No Abstract] [Full Text] [Related]
10. [Beta2 agonists and anticholinergics. Inhalation therapy in acute deterioriation of asthma and chronic obstructive pulmonary disease].
Ringbaek TJ; Phanareth K; Lange P
Ugeskr Laeger; 1996 Oct; 158(42):5957-62. PubMed ID: 8928288
[No Abstract] [Full Text] [Related]
11. Asthma and the beta 2-agonist controversy: much ado about something.
Lieberman JS; Kane GC
Del Med J; 1995 Dec; 67(12):624-8. PubMed ID: 8557164
[No Abstract] [Full Text] [Related]
12. Does salmeterol increase mortality in patients with COPD?
Gerber RB; Kavuru M
Cleve Clin J Med; 2001 Jul; 68(7):600-1. PubMed ID: 11453076
[No Abstract] [Full Text] [Related]
13. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
Ikeda A; Nishimura K; Izumi T
Chest; 1996 Jan; 109(1):294. PubMed ID: 8549208
[No Abstract] [Full Text] [Related]
14. Salmeterol.
Med Lett Drugs Ther; 1994 Apr; 36(921):37-9. PubMed ID: 7909139
[No Abstract] [Full Text] [Related]
15. [Therapy of asthma using bronchodilator agents--special reference to adrenergic beta 2-receptor agonists].
Kurosawa M; Igarashi Y; Miyachi Y
Nihon Naika Gakkai Zasshi; 1996 Feb; 85(2):210-5. PubMed ID: 8708449
[No Abstract] [Full Text] [Related]
16. Regular beta-agonist therapy--the quality of the evidence.
Sears MR; Taylor DR
Eur Respir J; 1992 Jul; 5(7):896-7, author reply 898-900. PubMed ID: 1354171
[No Abstract] [Full Text] [Related]
17. Response to inhaled bronchodilators in COPD.
Anthonisen NR; Wright EC
Chest; 1987 May; 91(5 Suppl):36S-39S. PubMed ID: 2882959
[No Abstract] [Full Text] [Related]
18. [A new long-acting asthma spray. Preliminary wait-and-see attitude?].
Flaten O
Tidsskr Nor Laegeforen; 1993 May; 113(13):1610. PubMed ID: 8101664
[No Abstract] [Full Text] [Related]
19. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
Ingram RH
Chest; 1996 Jan; 109(1):293. PubMed ID: 8549206
[No Abstract] [Full Text] [Related]
20. Beta-adrenergic bronchodilators.
Nelson HS
N Engl J Med; 1995 Aug; 333(8):499-506. PubMed ID: 7623883
[No Abstract] [Full Text] [Related]
[Next] [New Search]
